AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Health In Tech, Inc.

$0.91 -$0.84 (-48.25%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$0.93
Day Range
$0.89$1
Year Range
$0.85$4.02
Market Cap
48.78M
AVG Volume
153.84K
Trailing/Forward PE
-12.85/18.11
PEG ratio
0.09
Dividend Yield
-
Next Earnings Date
2026-11-09
Primary Exchange
NASDAQUS
Revenue (USD)
02.5M5M7.5M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q28.06M
26 Q18.77M
25 Q47.51M
25 Q38.49M
25 Q29.31M
25 Q18.01M
24 Q44.9M
24 Q34.46M
24 Q25M
24 Q15.12M
Net Income (USD)
-3M-2M-1M01M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-2.51M
26 Q1-1.59M
25 Q4-302.56K
25 Q3452.18K
25 Q2630.63K
25 Q1498.59K
24 Q4-144.15K
24 Q3376.09K
24 Q2338.01K
24 Q1100.54K
Operating Income (USD)
-4M-2M02M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-3.44M
26 Q1-2.16M
25 Q4-170.81K
25 Q3493.52K
25 Q2725.07K
25 Q1480.66K
24 Q4-316.34K
24 Q3438.88K
24 Q2534.94K
24 Q1332.42K
EBITDA (USD)
-4M-2M02M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-3.49M
26 Q1-1.66M
25 Q4-33.11K
25 Q3818.2K
25 Q2969.25K
25 Q1820.41K
24 Q425.23K
24 Q3707.32K
24 Q2701.06K
24 Q1491.52K
Cash Flows (USD)
-4M-2M02M4M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-2.55M
26 Q1-3.68M
25 Q4-380.5K
25 Q32.29M
25 Q2571.38K
25 Q1-176.12K
24 Q4-1.14M
24 Q32.05M
24 Q21.17M
24 Q1-813.61K
EPS (USD)
-0.04-0.0200.0224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.04
26 Q1-0.03
25 Q4-0.01
25 Q30.01
25 Q20.01
25 Q10.01
24 Q4-0
24 Q30.01
24 Q20.01
24 Q10
Expenses (USD)
-2.5M02.5M5M7.5MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q27M
26 Q17.03M
25 Q45.13M
25 Q33.04M
25 Q26.49M
25 Q15.58M
24 Q44.72M
24 Q33.11M
24 Q23.59M
24 Q13.94M
Cash & Debt (USD)
05M10M15MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q26.51M
26 Q110.33M
25 Q47.67M
25 Q38.02M
25 Q28.14M
25 Q17.58M
24 Q47.85M
24 Q31.75M
24 Q22.16M
24 Q11.36M
Debt ratios
-150-100-5005024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Debt ratios by quarter
PeriodDebt ratios
26 Q21.47
26 Q1-114.06
25 Q4-2.92
25 Q3-2.99
25 Q2-3.16
25 Q1-3.28
24 Q4-3.97
24 Q3-0.43
24 Q20.02
24 Q10.22
Margins
0%25%50%75%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Margins by quarter
PeriodMargins
26 Q248.69%
26 Q151.41%
25 Q454.99%
25 Q360.59%
25 Q267.75%
25 Q166.82%
24 Q477.43%
24 Q378.03%
24 Q280.52%
24 Q180.68%
Return on Capital
-15%-10%-5%0%5%10%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Return on Capital by quarter
PeriodReturn on Capital
26 Q2-12.8%
26 Q1-7.35%
25 Q4-1.77%
25 Q32.64%
25 Q23.84%
25 Q13.52%
24 Q4-1.09%
24 Q35.44%
24 Q25.17%
24 Q11.62%
Shares Outstanding
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Shares Outstanding by quarter
PeriodShares Outstanding
26 Q262.83M
26 Q157.35M
25 Q455.84M
25 Q356.43M
25 Q255.38M
25 Q154.62M
24 Q454.07M
24 Q354.07M
24 Q254.07M
24 Q154.07M
Book Value Per Share (USD)
00.10.20.30.424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q20.31
26 Q10.38
25 Q40.31
25 Q30.3
25 Q20.3
25 Q10.26
24 Q40.24
24 Q30.13
24 Q20.12
24 Q10.11
Total Assets (USD)
010M20M30M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HIT Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q231.06M
26 Q128.97M
25 Q423.09M
25 Q322.76M
25 Q222.18M
25 Q121.33M
24 Q415.77M
24 Q39.67M
24 Q210.76M
24 Q110.44M
Employee Count
025507510020242025
HIT Employee Count by quarter
PeriodEmployee Count
202587
202473
PE Ratio
050100150200250med 63.83Jan 25Apr 25Jul 25Sep 25Dec 25Feb 26May 26
HIT PE Ratio by quarter
PeriodPE Ratio
May 2668.12
May 2667.68
Apr 2665.94
Apr 2665.5
Apr 2658.51
Apr 2662.88
Mar 2660.7
Mar 2670.68
Mar 2670.68
Mar 2673.03
Feb 2655.36
Feb 2646.72
Feb 2642.8
Feb 2641.23
Jan 2645.55
Jan 2656.93
Jan 2656.15
Jan 2664.79
Jan 2668.71
Dec 2560.07
Dec 2553.4
Dec 2541.62
Dec 2544.76
Nov 2559.68
Nov 2554.58
Nov 2562.82
Nov 25118.4
Oct 25107.82
Oct 25119.62
Oct 25122.88
Oct 25139.15
Oct 25137.12
Sep 25135.49
Sep 25146.07
Sep 25107.42
Sep 25111.08
Aug 25111.89
Aug 25140.37
Aug 25143.22
Aug 25100.91
Aug 25102.24
Jul 2594.06
Jul 2559.3
Jul 2557.76
Jul 2543.5
Jun 2542.28
Jun 2531.9
Jun 2530.52
Jun 2532.2
May 2531.18
May 2533.18
May 2531.74
May 2541.82
May 2550.64
Apr 2553.55
Apr 2555.24
Apr 2556.45
Apr 2547.58
Mar 2554.84
Mar 2552.9
Mar 2524.28
Mar 25212.77
Feb 25209.8
Feb 25197
Feb 25177.66
Feb 25165.46
Jan 25164.27
Jan 25153.55
Jan 25171.41
Jan 25154.45
Jan 25158.91
Dec 24162.48
Free Cash Flow Yield
-10%-5%0%5%10%med 1.52%Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
HIT Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-7.6%
Sep 26-7.02%
Aug 26-7.02%
Aug 26-6.88%
Aug 26-6.88%
Aug 26-1.87%
Jul 26-1.89%
Jul 26-1.98%
Jul 26-1.86%
Jul 26-1.98%
Jul 26-2.08%
Jun 26-2.02%
Jun 26-1.94%
Jun 26-1.96%
Jun 26-2.13%
May 26-2.11%
May 26-2.33%
May 26-1.98%
May 262.64%
May 262.66%
Apr 262.73%
Apr 262.75%
Apr 263.08%
Apr 262.86%
Mar 262.97%
Mar 261.52%
Mar 261.52%
Mar 261.47%
Feb 261.94%
Feb 262.3%
Feb 262.51%
Feb 262.61%
Jan 262.36%
Jan 261.89%
Jan 261.91%
Jan 261.66%
Jan 261.56%
Dec 251.79%
Dec 252.01%
Dec 252.58%
Dec 252.4%
Nov 251.8%
Nov 251.97%
Nov 251.71%
Nov 250.81%
Oct 250.89%
Oct 250.81%
Oct 250.78%
Oct 250.69%
Oct 250.7%
Sep 250.71%
Sep 250.66%
Sep 250.9%
Sep 250.87%
Aug 250.86%
Aug 250.69%
Aug 250.67%
Aug 250.96%
Aug 251.75%
Jul 251.9%
Jul 253.02%
Jul 253.1%
Jul 254.12%
Jun 254.23%
Jun 255.61%
Jun 255.87%
Jun 255.56%
May 255.74%
May 255.4%
May 255.64%
May 254.28%
May 253.76%
Apr 253.55%
Apr 253.44%
Apr 253.37%
Apr 254%
Mar 253.47%
Mar 253.6%
Mar 253.92%
Mar 250.45%
Feb 250.45%
Feb 250.48%
Feb 250.54%
Feb 250.58%
Jan 250.58%
Jan 250.62%
Jan 250.56%
Jan 250.62%
Jan 250.6%
Dec 240.59%
Price to Sales
05101520med 2.51Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
HIT Price to Sales by quarter
PeriodPrice to Sales
Sep 261.73
Sep 261.88
Aug 261.88
Aug 261.91
Aug 261.91
Aug 261.88
Jul 261.87
Jul 261.78
Jul 261.9
Jul 261.78
Jul 261.7
Jun 261.75
Jun 261.82
Jun 261.8
Jun 261.66
May 261.67
May 261.51
May 261.78
May 262.61
May 262.6
Apr 262.53
Apr 262.51
Apr 262.25
Apr 262.41
Mar 262.33
Mar 263.31
Mar 263.31
Mar 263.42
Feb 262.59
Feb 262.19
Feb 262
Feb 261.93
Jan 262.13
Jan 262.66
Jan 262.63
Jan 263.03
Jan 263.21
Dec 252.81
Dec 252.5
Dec 251.95
Dec 252.09
Nov 252.79
Nov 252.55
Nov 252.94
Nov 256.04
Oct 255.5
Oct 256.1
Oct 256.27
Oct 257.1
Oct 256.99
Sep 256.91
Sep 257.45
Sep 255.48
Sep 255.66
Aug 255.71
Aug 257.16
Aug 257.3
Aug 255.15
Aug 254.88
Jul 254.49
Jul 252.83
Jul 252.76
Jul 252.08
Jun 252.02
Jun 251.52
Jun 251.46
Jun 251.54
May 251.49
May 251.58
May 251.52
May 252
May 251.74
Apr 251.84
Apr 251.9
Apr 251.94
Apr 251.64
Mar 251.89
Mar 251.82
Mar 252.23
Mar 2519.52
Feb 2519.25
Feb 2518.08
Feb 2516.3
Feb 2515.18
Jan 2515.07
Jan 2514.09
Jan 2515.73
Jan 2514.17
Jan 2514.58
Dec 2414.91
EV/EBITDA
0200400600800med 35.59Feb 25May 25Aug 25Nov 25Feb 26May 26Aug 26
HIT EV/EBITDA by quarter
PeriodEV/EBITDA
Aug 26603.98
Jul 26597.57
Jul 26565.51
Jul 26610.39
Jul 26565.51
Jul 26533.46
Jun 26552.69
Jun 26578.33
Jun 26571.92
Jun 26518.71
May 26521.98
May 26461.97
May 26565.51
May 2630.91
May 2630.69
Apr 2629.83
Apr 2629.61
Apr 2626.14
Apr 2628.31
Mar 2627.22
Mar 2635.59
Mar 2635.59
Mar 2636.88
Feb 2627.23
Feb 2622.52
Feb 2620.37
Feb 2619.52
Jan 2621.87
Jan 2628.09
Jan 2627.66
Jan 2632.38
Jan 2634.52
Dec 2529.8
Dec 2526.16
Dec 2519.73
Dec 2521.44
Nov 2529.59
Nov 2526.8
Nov 2531.3
Nov 2560.74
Oct 2555.03
Oct 2561.4
Oct 2563.16
Oct 2571.94
Oct 2570.84
Sep 2569.96
Sep 2575.67
Sep 2554.81
Sep 2556.79
Aug 2557.23
Aug 2572.6
Aug 2574.13
Aug 2551.3
Aug 2545.19
Jul 2541.31
Jul 2524.83
Jul 2524.11
Jul 2517.35
Jun 2516.76
Jun 2511.85
Jun 2511.19
Jun 2511.99
May 2511.51
May 2512.45
May 2511.77
May 2516.55
May 2513.67
Apr 2514.68
Apr 2515.27
Apr 2515.69
Apr 2512.6
Mar 2515.13
Mar 2514.45
Mar 2512.13
Mar 25109.62
Feb 25108.08
Feb 25101.46
Feb 2591.46
Feb 2585.14
Jan 2584.53
Jan 2578.99
Jan 2588.22
Jan 2579.45
Jan 2581.76
Dec 2483.61
Price/Operating Cashflow
050100150200med 36.72Jan 25Apr 25Jul 25Sep 25Dec 25Feb 26May 26
HIT Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
May 2627.8
May 2627.62
Apr 2626.91
Apr 2626.73
Apr 2623.88
Apr 2625.66
Mar 2624.77
Mar 2647.21
Mar 2647.21
Mar 2648.79
Feb 2636.98
Feb 2631.21
Feb 2628.59
Feb 2627.54
Jan 2630.43
Jan 2638.03
Jan 2637.51
Jan 2643.28
Jan 2645.9
Dec 2540.13
Dec 2535.67
Dec 2527.8
Dec 2529.9
Nov 2539.87
Nov 2536.46
Nov 2541.97
Nov 2544.79
Oct 2540.78
Oct 2545.25
Oct 2546.48
Oct 2552.64
Oct 2551.87
Sep 2551.25
Sep 2555.25
Sep 2540.63
Sep 2542.02
Aug 2542.32
Aug 2553.1
Aug 2554.17
Aug 2538.17
Aug 2532.28
Jul 2529.7
Jul 2518.73
Jul 2518.24
Jul 2513.74
Jun 2513.35
Jun 2510.07
Jun 259.64
Jun 2510.17
May 259.85
May 2510.48
May 2510.02
May 2513.2
May 2515.6
Apr 2516.5
Apr 2517.02
Apr 2517.39
Apr 2514.66
Mar 2516.9
Mar 2516.3
Mar 2519.17
Mar 25167.95
Feb 25165.61
Feb 25155.5
Feb 25140.24
Feb 25130.6
Jan 25129.67
Jan 25121.21
Jan 25135.3
Jan 25121.91
Jan 25125.44
Dec 24128.26
Price to Book
0204060med 4.55Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
HIT Price to Book by quarter
PeriodPrice to Book
Sep 262.9
Sep 263.14
Aug 263.14
Aug 263.2
Aug 263.2
Aug 262.97
Jul 262.95
Jul 262.81
Jul 263
Jul 262.81
Jul 262.68
Jun 262.76
Jun 262.87
Jun 262.84
Jun 262.62
May 262.63
May 262.39
May 262.81
May 265.09
May 265.06
Apr 264.93
Apr 264.9
Apr 264.37
Apr 264.7
Mar 264.54
Mar 265.92
Mar 265.92
Mar 266.12
Feb 264.64
Feb 263.91
Feb 263.58
Feb 263.45
Jan 263.81
Jan 264.77
Jan 264.7
Jan 265.43
Jan 265.76
Dec 255.03
Dec 254.47
Dec 253.49
Dec 253.75
Nov 255
Nov 254.57
Nov 255.26
Nov 259.81
Oct 258.94
Oct 259.91
Oct 2510.18
Oct 2511.53
Oct 2511.36
Sep 2511.23
Sep 2512.11
Sep 258.9
Sep 259.21
Aug 259.27
Aug 2511.63
Aug 2511.87
Aug 258.36
Aug 257.71
Jul 257.1
Jul 254.47
Jul 254.36
Jul 253.28
Jun 253.19
Jun 252.41
Jun 252.3
Jun 252.43
May 252.35
May 252.5
May 252.4
May 253.16
May 252.58
Apr 252.73
Apr 252.81
Apr 252.87
Apr 252.42
Mar 252.79
Mar 252.69
Mar 256.39
Mar 2555.96
Feb 2555.18
Feb 2551.82
Feb 2546.73
Feb 2543.52
Jan 2543.21
Jan 2540.39
Jan 2545.08
Jan 2540.62
Jan 2541.8
Dec 2442.74
Health In Tech, Inc.
HIT
Stockpicker

Video analysis: HIT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: HIT

Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026

prnewswire.com · 9 Sep 2026

Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026

Health In Tech recognized among the 100 highest-scoring U.S. public mid-market companies following an initial review of approximately 4,300 companies, based on financial strength, workforce performance, innovation and sustainability STUART, Fla., Sept. 9, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, announced today that it has been named one of Newsweek's America's Greatest Mid-Market Companies 2026.

Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript

seekingalpha.com · 13 Aug 2026

Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript

Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript

Health In Tech Q2 Earnings Call Highlights

marketbeat.com · 13 Aug 2026

Health In Tech Q2 Earnings Call Highlights

Health In Tech NASDAQ: HIT reported second-quarter revenue of $8.1 million, down 13.5% from $9.3 million in the year-earlier period, as the company said the onboarding of a new carrier shifted certain policy effective dates into later quarters.

Health In Tech Reports Second Quarter 2026 Financial Results

prnewswire.com · 13 Aug 2026

Health In Tech Reports Second Quarter 2026 Financial Results

Contracted Revenue of $32.3 Million as of June 30, 2026 Pipeline Revenue of $66.3 Million as of July 31, 2026 Distribution Partners Grew 19.9% Year Over Year STUART, Fla., Aug. 13, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three and six months ended June 30, 2026.

Health In Tech to Announce Second Quarter 2026 Financial Results on August 13, 2026

prnewswire.com · 3 Aug 2026

Health In Tech to Announce Second Quarter 2026 Financial Results on August 13, 2026

STUART, Fla., Aug. 3, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the second quarter ended June 30, 2026, following the close of market on Wednesday, August 13, 2026.

Health In Tech Added to Membership of Russell Microcap® Index

prnewswire.com · 29 Jun 2026

Health In Tech Added to Membership of Russell Microcap® Index

STUART, Fla., June 29, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company") was added as a member of the Russell Microcap® Index, effective when the U.S. market opens on June 29, 2026, as part of the 2026 Russell U.S. indexes reconstitution.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.